Search

Your search keyword '"Medway, C."' showing total 84 results

Search Constraints

Start Over You searched for: Author "Medway, C." Remove constraint Author: "Medway, C."
84 results on '"Medway, C."'

Search Results

1. Genetically elevated high‐density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

2. The Epistasis Project: A Multi-Cohort Study of the Effects of BDNF, DBH, and SORT1 Epistasis on Alzheimer's Disease Risk

5. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A beta, tau, immunity and lipid processing (vol 51, pg 414, 2019)

6. Nat Genet

7. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

8. Polygenic risk and hazard scores for Alzheimer's disease prediction

9. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing

10. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

11. Meta-analysis of genetic association with diagnosed Alzheimer's disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

12. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

13. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

14. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

15. Influence of coding variability in APP-Aß metabolism genes in sporadic Alzheimer's disease

16. ABCA7 p.G215S as potential protective factor for Alzheimer’s disease

17. A novel Alzheimer disease locus located near the gene encoding tau protein

18. ABCA7 p.G215S as potential protective factor for Alzheimer's disease

19. ABCA7 p.G215S as potential protective factor for Alzheimer's disease

20. The genetics of Alzheimer's disease: putting flesh on the bones

21. TREM2 variants in Alzheimer's disease

22. Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease

23. Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia

24. Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease

25. Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease

26. A multi-center study of ACE and the risk of late-onset Alzheimer's disease.

28. Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

31. Using in silico LD clumping and meta-analysis of genomewide datasets as a complementary tool to investigate and validate new candidate biomarkers in Alzheimer's disease

32. ABCA7 p.G215S as potential protective factor for Alzheimer’s disease

33. The genetics of Alzheimer's disease: putting flesh on the bones

34. The genetics of Alzheimer's disease: putting flesh on the bones

35. ABCA7 p.G215S as potential protective factor for Alzheimer’s disease

36. The genetics of Alzheimer's disease: putting flesh on the bones

37. ABCA7 p.G215S as potential protective factor for Alzheimer’s disease

38. The genetics of Alzheimer's disease: putting flesh on the bones

39. ABCA7 p.G215S as potential protective factor for Alzheimer’s disease

40. Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's Disease.

41. Pharmacogenomic Variants and Drug Interactions Identified Through the Genetic Analysis of Clozapine Metabolism.

42. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

43. FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat.

44. TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's disease.

45. Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3.

46. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.

47. A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.

48. Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array.

49. ABCA7 p.G215S as potential protective factor for Alzheimer's disease.

50. Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer's Disease.

Catalog

Books, media, physical & digital resources